Literature DB >> 35003784

Long COVID Mimicking Interstitial Lung Disease: A Case Series.

Nitin Goel1, Nitesh Goyal1, Raj Kumar1.   

Abstract

Interstitial lung diseases (ILD) can occur due to various known or unknown causes. They usually present with dry cough and exertional dyspnea. On radiology usual findings are ground glass opacities (GGO's), reticular shadows, nodules etc. Some patients after acute COVID-19 (coronavirus disease 2019) suffer from persistent symptoms/manifestations. These have been called 'Long COVID'. Long COVID also has radiological features like GGO's, nodules and reticulations. Further, patients even without history of acute COVID-19, can also present with 'Long COVID'. In the present case series, we describe three such cases with no history of having suffered from COVID-19, presenting with ILD like features and diagnosed as Long COVID. We infer from these cases that 'Long COVID' can both clinically and radiologically mimic ILD's. Hence, emphasizing the fact that in the present COVID-19 pandemic situation, 'Long COVID should be a differential diagnosis to be considered while making a new diagnosis of ILD.
Copyright © 2014, Medical University Publishing House Craiova.

Entities:  

Keywords:  COVID-19 RT-PCR Testing; COVID19; IgG; Interstitial Lung Disease; SARS-CoV-2

Year:  2021        PMID: 35003784      PMCID: PMC8679157          DOI: 10.12865/CHSJ.47.03.22

Source DB:  PubMed          Journal:  Curr Health Sci J


Introduction

Pulmonary interstitium, referred to as supportive tissue around the alveoli, is commonly involved in interstitial lung diseases (ILDs) [1]. Involvement of pulmonary interstitium can occur due to some known and other unknown aetiologies [2]. Organic and inorganic dust, various drugs and infections can cause one or the other form of ILD [3]. SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) has emerged as a potentially hazardous infection in the recent times [4]. Lungs are among the most commonly involved organs [5]. The severity of the disease can range from mild symptoms to a life-threatening infection [6,7]. COVID-19 (Coronavirus Disease 2019) infection of the lungs shows various CT (Computed Tomography) manifestations mimicking ILD including ground glass opacities, septal thickening and/or reticulations, crazy paving pattern and nodules [8]. Although these findings are more common in severe COVID 19, cases with mild disease can also have such features [9]. In this case series we describe three patients without any history suggestive of acute COVID and presentation similar to interstitial lung diseases, but were subsequently confirmed as cases of ‘Long COVID’ [10]. The present work was part of project approved by the Institute Human Ethics Committee (IHEC).

Cases

We had three patients presenting to us with history of dry cough and insidious onset exertional breathlessness. The duration of symptoms varied from 6-10 weeks. None of them had any history of prior respiratory ailments. Clinical-radiological findings were suggestive of ILD (Table 1).
Table 1

Comparison of various parameters among three cases

Parameters

Case 1

Case 2

Case 3

Age (Years)

56

65

53

Gender

Male

Male

Male

Diabetes Mellitus (Duration)

No

Yes (15 years)

Yes (16 years)

Hypertension (Duration)

No

No

Yes (2 years)

Symptoms

Cough and exertional dyspnea for 6 weeks

Cough, exertional dyspnea and chest pain for 8 weeks

Cough and exertional dyspnea for 10 weeks

Auscultatory findings

Bilateral infrascapular inspiratory fine crepts

Bilateral infrascapular inspiratory fine crepts

Bilateral infrascapular inspiratory fine crepts

Baseline Chest X-ray

Bilateral diffuse reticulations

(Figure 1a)

Bilateral lower zone reticulations

Bilateral lower zone reticulations

Baseline CT Chest

Diffuse patches of ground glass opacities (GGOs) (Figure 2a)

Bilateral peripheral GGOs in lower lobes

(Figure 3a)

Bilateral lower lobe reticulations

(Figure 4a)

COVID Antibody level

(in OD ratio)

2.10

4.0

5.4

Treatment given

Oral corticosteroids in tapering doses for 4 weeks

Oral corticosteroids in tapering doses for 2 weeks

Oral corticosteroids in tapering doses for 2 weeks

Post treatment Radiology

Clearing of reticulations & GGOs

(Figures 1b & 2b)

Clearing of GGOs

(Figure 3b)

Clearing of reticulations

(Figure 4b)

RT-PCR for COVID-19 was negative in all three patients. All serological investigations for ruling out various ILD were negative. In view of the current COVID-19 pandemic status, the patients were subjected to IgG antibodies test against SARS-COV-2, which was found to be positive in all three of them. Based on above findings, these patients were diagnosed as ‘Long COVID’. They were started on short course of systemic corticosteroids. Post-treatment clinical and radiological profile of all three patients showed improvement. Also, a written informed consent was obtained from all the patients before publication of their data. Comparison of various parameters among three cases Parameters Case 1 Case 2 Case 3 Age (Years) 56 65 53 Gender Male Male Male Diabetes Mellitus (Duration) No Yes (15 years) Yes (16 years) Hypertension (Duration) No No Yes (2 years) Symptoms Cough and exertional dyspnea for 6 weeks Cough, exertional dyspnea and chest pain for 8 weeks Cough and exertional dyspnea for 10 weeks Auscultatory findings Bilateral infrascapular inspiratory fine crepts Bilateral infrascapular inspiratory fine crepts Bilateral infrascapular inspiratory fine crepts Baseline Chest X-ray Bilateral diffuse reticulations (Figure 1a)
Figure 1

(a), Case 1 Chest X-ray (posteroanterior view) showing bilateral diffuse reticulations; (b), Case 1 showing clearing of reticulations after 7 weeks

Bilateral lower zone reticulations Bilateral lower zone reticulations Baseline CT Chest Diffuse patches of ground glass opacities (GGOs) (Figure 2a)
Figure 2

(a), Case 1 CT scan of chest showing patchy areas of ground glass opacities. (b), Case 1 showing clearing of ground glass opacities after 7 weeks

Bilateral peripheral GGOs in lower lobes (Figure 3a)
Figure 3

(a), Case 2 CT scan of chest showing diffuse ground glass opacities with interstitial thickening; (b), Case 2 showing clearing of ground glass opacities after 10 weeks

Bilateral lower lobe reticulations (Figure 4a)
Figure 4

(a), Case 3 CT scan of chest showing bilateral lower lobe reticulations; (b), Case 3 showing clearing of reticulations after 12 weeks

COVID Antibody level (in OD ratio) 2.10 4.0 5.4 Treatment given Oral corticosteroids in tapering doses for 4 weeks Oral corticosteroids in tapering doses for 2 weeks Oral corticosteroids in tapering doses for 2 weeks Post treatment Radiology Clearing of reticulations & GGOs (Figures 1b & 2b) Clearing of GGOs (Figure 3b) Clearing of reticulations (Figure 4b) (a), Case 1 Chest X-ray (posteroanterior view) showing bilateral diffuse reticulations; (b), Case 1 showing clearing of reticulations after 7 weeks (a), Case 1 CT scan of chest showing patchy areas of ground glass opacities. (b), Case 1 showing clearing of ground glass opacities after 7 weeks (a), Case 2 CT scan of chest showing diffuse ground glass opacities with interstitial thickening; (b), Case 2 showing clearing of ground glass opacities after 10 weeks (a), Case 3 CT scan of chest showing bilateral lower lobe reticulations; (b), Case 3 showing clearing of reticulations after 12 weeks

Discussion

Corona Virus Disease 2019 (COVID 19) has emerged as a public health emergency [11]. The disease severity can range from mild infection to a severe one [12]. Patients suffering from severe disease are more at risk of developing complications including lung fibrosis. But in the literature, cases have been reported of patient with mild diseases having severe cardiorespiratory complications including sudden death [9]. Patients with mild infection have minimal symptoms or are often asymptomatic. And the infection can go unrecognized until some complications develop. Our case series highlights the importance of this fact. We described 3 cases, who presented to the hospital with a short history of respiratory symptoms and evidence of lung fibrosis. All of them had tested negative for the SARS-CoV-2 by RT-PCR. On presentation these patients had dry cough, exertional dyspnea, bibasilar crepitations on auscultation, bilateral reticulations on chest radiography and ground glass opacities in CT scan of the chest. Hence, ILD was the probable diagnosis in these cases. But considering the current COVID pandemic situation the possibility of COVID 19 infection as a differential diagnosis was also kept. IgG antibodies against SARS-CoV-2 were found to be positive in all the cases, confirming a diagnosis of past COVID-19 infection with residual disease i.e., ‘Long COVID’. ILD are an important differential diagnosis of patients with exertional dyspnea, dry cough and bilateral reticular/ground glass shadows on radiology, when infections/malignancy have been ruled out. Interstitial lung involvement in sarcoidosis, acute hypersensitivity pneumonitis, eosinophilic pneumonias and idiopathic interstitial pneumonias can show ground glass opacities [13]. The common radiographic patterns observed in Long COVID includes diffuse reticulations, diffuse nodular shadows and diffuse ground glass opacities [14]. These radiologic patterns hence, mimic those seen in ILDs. Whereas the treatment guidelines are defined in the literature for most of the ILDs, not much literature evidence is available for the pharmacological management of ‘Long COVID’. So, it is very important to diagnose long COVID patient before labelling it as some idiopathic form of ILD based on the radiology. Idiopathic form of ILD is termed when no underlying cause or association is found. In the present pandemic, many patients are recovering from the COVID and are suffering from manifestations of Long COVID. All the three patients in the present case series did not have any symptoms/history suggestive of acute COVID. Despite this they had manifestations of ‘Long COVID’ as confirmed by suggestive radiology and positive serology for SARS-CoV-2. This case series highlights the importance of considering ‘Long COVID’ disease as a differential to the diseases with interstitial involvement with short history at presentation. After making a diagnosis of long COVID, these patients were treated with tapering doses of systemic corticosteroids which helped in clinical and radiological recovery. Other studies have also found similar outcomes on usage of systemic corticosteroids in long COVID patients [15,16,17]. There were limitations in the present study, Firstly, owing to the COVID pandemic situation bronchoscopy and pulmonary function tests could not be performed in these patients. Secondly, this is a small sample observation and would benefit from large scale studies. Further, a longer duration follow up would add to the observations.

Conclusions

The clinical and radiological presentation of ‘Long COVID’ resembles that of ILD’s. Further asymptomatic COVID infection can also manifest signs and symptoms of ‘Long COVID’. Therefore, in the current COVID-19 pandemic situation, patients with short history of respiratory symptoms and radiological features suggestive of ILD’s-‘Long COVID’ should also be ruled out, before making a diagnosis of ILD.

Conflict of interest

None to declare.
  14 in total

1.  Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society.

Authors:  B Bradley; H M Branley; J J Egan; M S Greaves; D M Hansell; N K Harrison; N Hirani; R Hubbard; F Lake; A B Millar; W A H Wallace; A U Wells; M K Whyte; M L Wilsher
Journal:  Thorax       Date:  2008-09       Impact factor: 9.139

Review 2.  [Is there a post-COVID syndrome?]

Authors:  Bernd Lamprecht
Journal:  Pneumologe (Berl)       Date:  2020-10-08

3.  Clinico-radiological evaluation of post COVID-19 at a tertiary pulmonary care centre in Delhi, India.

Authors:  Nitin Goel; Nitesh Goyal; Raj Kumar
Journal:  Monaldi Arch Chest Dis       Date:  2021-03-08

4.  Gross and histopathological pulmonary findings in a COVID-19 associated death during self-isolation.

Authors:  Christine Suess; Roland Hausmann
Journal:  Int J Legal Med       Date:  2020-06-05       Impact factor: 2.686

Review 5.  Organ-specific manifestations of COVID-19 infection.

Authors:  Maria Gavriatopoulou; Eleni Korompoki; Despina Fotiou; Ioannis Ntanasis-Stathopoulos; Theodora Psaltopoulou; Efstathios Kastritis; Evangelos Terpos; Meletios A Dimopoulos
Journal:  Clin Exp Med       Date:  2020-07-27       Impact factor: 3.984

6.  Mild versus severe COVID-19: Laboratory markers.

Authors:  Thirumalaisamy P Velavan; Christian G Meyer
Journal:  Int J Infect Dis       Date:  2020-04-25       Impact factor: 3.623

7.  Persistent Post-COVID-19 Interstitial Lung Disease. An Observational Study of Corticosteroid Treatment.

Authors:  Katherine Jane Myall; Bhashkar Mukherjee; Ana Margarida Castanheira; Jodie L Lam; Giulia Benedetti; Sze Mun Mak; Rebecca Preston; Muhunthan Thillai; Amy Dewar; Philip L Molyneaux; Alex G West
Journal:  Ann Am Thorac Soc       Date:  2021-05

8.  Exploring Clinical and Epidemiological Characteristics of Interstitial Lung Diseases: Rationale, Aims, and Design of a Nationwide Prospective Registry--The EXCITING-ILD Registry.

Authors:  Michael Kreuter; Felix J F Herth; Margarethe Wacker; Reiner Leidl; Andreas Hellmann; Michael Pfeifer; Jürgen Behr; Sabine Witt; Dagmar Kauschka; Marcus Mall; Andreas Günther; Philipp Markart
Journal:  Biomed Res Int       Date:  2015-11-10       Impact factor: 3.411

9.  Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan.

Authors:  Xiaochen Li; Shuyun Xu; Muqing Yu; Ke Wang; Yu Tao; Ying Zhou; Jing Shi; Min Zhou; Bo Wu; Zhenyu Yang; Cong Zhang; Junqing Yue; Zhiguo Zhang; Harald Renz; Xiansheng Liu; Jungang Xie; Min Xie; Jianping Zhao
Journal:  J Allergy Clin Immunol       Date:  2020-04-12       Impact factor: 10.793

10.  Chest CT in COVID-19: What the Radiologist Needs to Know.

Authors:  Thomas C Kwee; Robert M Kwee
Journal:  Radiographics       Date:  2020-10-23       Impact factor: 5.333

View more
  1 in total

Review 1.  Unbalanced IDO1/IDO2 Endothelial Expression and Skewed Keynurenine Pathway in the Pathogenesis of COVID-19 and Post-COVID-19 Pneumonia.

Authors:  Marco Chilosi; Claudio Doglioni; Claudia Ravaglia; Guido Martignoni; Gian Luca Salvagno; Giovanni Pizzolo; Vincenzo Bronte; Venerino Poletti
Journal:  Biomedicines       Date:  2022-06-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.